Condition
Cornelia de Lange Syndrome
Total Trials
6
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting4
Not Yet Recruiting1
Terminated1
Clinical Trials (6)
Showing 6 of 6 trials
NCT04381897Phase 2Not Yet RecruitingPrimary
Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
NCT05829668Not ApplicableRecruitingPrimary
Behavioral Assessment and Treatment of Problem Behavior in Children With Cornelia de Lange Syndrome
NCT01793168Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT06789783Phase 2RecruitingPrimary
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment
NCT04463316Recruiting
GROWing Up With Rare GENEtic Syndromes
NCT03113877TerminatedPrimary
Evaluation of Autonomic Function in Individuals With Cornelia de Lange Syndrome (CdLS)
Showing all 6 trials